International Journal of Clinical Pharmacy

, Volume 36, Issue 4, pp 669–674 | Cite as

The Utrecht Pharmacy Practice network for Education and Research: a network of community and hospital pharmacies in the Netherlands

  • Ellen S. KosterEmail author
  • Lyda Blom
  • Daphne Philbert
  • Willem Rump
  • Marcel L. Bouvy


Practice-based networks can serve as effective mechanisms for the development of the profession of pharmacists, on the one hand by supporting student internships and on the other hand by collection of research data and implementation of research outcomes among public health practice settings. This paper presents the characteristics and benefits of the Utrecht Pharmacy Practice network for Education and Research, a practice based research network affiliated with the Department of Pharmaceutical Sciences of Utrecht University. Yearly, this network is used to realize approximately 600 student internships (in hospital and community pharmacies) and 20 research projects. To date, most research has been performed in community pharmacy and research questions frequently concerned prescribing behavior or adherence and subjects related to uptake of regulations in the pharmacy setting. Researchers gain access to different types of data from daily practice, pharmacists receive feedback on the functioning of their own pharmacy and students get in depth insight into pharmacy practice.


Pharmacy practice Research network The Netherlands UPPER 



The authors would like to acknowledge all the pharmacies participating in the UPPER network.



Conflicts of interest

No conflicts of interest to declare.


  1. 1.
    van Mil JW. Pharmaceutical care in community pharmacy: practice and research in the Netherlands. Ann Pharmacother. 2005;39(10):1720–5.PubMedCrossRefGoogle Scholar
  2. 2.
    Mays GP, Hogg RA, Castellanos-Cruz DM, Hoover AG, Fowler LC. Public health research implementation and translation: evidence from practice-based research networks. Am J Prev Med. 2013;45(6):752–62.PubMedCrossRefGoogle Scholar
  3. 3.
    Marinac JS, Kuo GM. Characterizing the American college of clinical pharmacy practice-based research network. Pharmacotherapy. 2010;30(8):865.PubMedCrossRefGoogle Scholar
  4. 4.
    Goode JV, Mott DA, Chater R. Collaborations to facilitate success of community pharmacy practice-based research networks. J Am Pharm Assoc (2003). 2008;48(2):153–62.CrossRefGoogle Scholar
  5. 5.
    Pruchnicki MC, Rodis JL, Beatty SJ, Clark C, McAuley JW, Mehta BW, et al. Practice-based research network as a research training model for community/ambulatory pharmacy residents. J Am Pharm Assoc (2003). 2008;48(2):191–202.CrossRefGoogle Scholar
  6. 6.
    Peterson GM, Jackson SL, Fitzmaurice KD, Gee PR. Attitudes of Australian pharmacists towards practice-based research. J Clin Pharm Ther. 2009;34(4):397–405.PubMedCrossRefGoogle Scholar
  7. 7.
    Hebert J, Laliberte MC, Berbiche D, Martin E, Lalonde L. The willingness of community pharmacists to participate in a practice-based research network. Can Pharm J (Ott). 2013;146(1):47–54.CrossRefGoogle Scholar
  8. 8.
    Koster ES, Walgers JC, van Grinsven MC, Winters NA, Bouvy ML. Adherence to national recommendations for safe methotrexate dispensing in community pharmacies. J Manag Care Pharm. 2014;20(2):194–200.PubMedGoogle Scholar
  9. 9.
    van Geffen EC, van Hulten R, Bouvy ML, Egberts AC, Heerdink ER. Characteristics and reasons associated with nonacceptance of selective serotonin-reuptake inhibitor treatment. Ann Pharmacother. 2008;42(2):218–25.PubMedCrossRefGoogle Scholar
  10. 10.
    Zuidgeest MG, Koster ES, Maitland-van der Zee AH, Smit AH, Brunekreef B, Leufkens HG, et al. Asthma therapy during the first 8 years of life: a PIAMA cohort study. J Asthma. 2010;47(2):209–13.PubMedCrossRefGoogle Scholar
  11. 11.
    Floor-Schreudering A, De Smet PA, Buurma H, Egberts AC, Bouvy ML. Documentation quality in community pharmacy: completeness of electronic patient records after patients’ first visits. Ann Pharmacother. 2009;43(11):1787–94.PubMedCrossRefGoogle Scholar
  12. 12.
    Koster ES, Raaijmakers JA, Koppelman GH, Postma DS, van der Ent CK, Koenderman L, et al. Pharmacogenetics of anti-inflammatory treatment in children with asthma: rationale and design of the PACMAN cohort. Pharmacogenomics. 2009;10(8):1351–61.PubMedCrossRefGoogle Scholar
  13. 13.
    Fietje EH, Philbert D, van Geffen EC, Winters NA, Bouvy ML. Adherence to oseltamivir guidelines during influenza pandemic, the Netherlands. Emerg Infect Dis. 2012;18(3):534–5.PubMedCentralPubMedCrossRefGoogle Scholar
  14. 14.
    Koster ES, Blom L, Winters NA, van Hulten RP, Bouvy ML. Interpretation of drug label instructions: a study among four immigrants groups in the Netherlands. Int J Clin Pharm. 2014;36(2):274–81.PubMedCrossRefGoogle Scholar
  15. 15.
    Floor-Schreudering A, Smet PA, Buurma H, Kramers C, Tromp PC, Belitser SV, et al. NSAID-antihypertensive drug interactions: which outpatients are at risk for a rise in systolic blood pressure? Eur J Prev Cardiol. 2013; september 16 [Epub ahead of print].Google Scholar
  16. 16.
    Wouters H, van Geffen EC, Baas-Thijssen MC, Krol-Warmerdam EM, Stiggelbout AM, Belitser S, et al. Disentangling breast cancer patients’ perceptions and experiences with regard to endocrine therapy: nature and relevance for non-adherence. Breast. 2013;22(5):661–6.PubMedCrossRefGoogle Scholar
  17. 17.
    Wouters H, Maatman GA, Van Dijk L, Bouvy ML, Vree R, van Geffen EC, et al. Trade-off preferences regarding adjuvant endocrine therapy among women with estrogen receptor-positive breast cancer. Ann Oncol. 2013;24(9):2324–9.PubMedCrossRefGoogle Scholar
  18. 18.
    Holsappel IG, Koster ES, Winters NA, Bouvy ML. Prescribing with indication: uptake of regulations in current practice and patients opinions in the Netherlands. Int J Clin Pharm. 2014;36(2):282–6.PubMedCrossRefGoogle Scholar

Copyright information

© Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie 2014

Authors and Affiliations

  • Ellen S. Koster
    • 1
    Email author
  • Lyda Blom
    • 1
  • Daphne Philbert
    • 1
  • Willem Rump
    • 1
  • Marcel L. Bouvy
    • 1
  1. 1.UPPER, Division of Pharmacoepidemiology and Clinical Pharmacology, Faculty of Science, Utrecht Institute of SciencesUtrecht UniversityUtrechtThe Netherlands

Personalised recommendations